Genprex, Inc. (GNPX) DCF Valuation

Genprex, Inc. (GNPX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Genprex, Inc. (GNPX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (GNPX) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Genprex, Inc., you can adjust forecasts and see the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -10.6 -17.9 -20.6 -23.8 -31.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -10.7 -18.0 -20.7 -23.8 -31.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.0 27.3 38.6 21.0 6.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .8 3.0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .4 .2 1.0 .4 1.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.9 -2.3 -.1 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -10.7 -17.9 -20.7 -29.6 -31.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.0 -22.7 -16.9 -30.2 -30.1 -1.4 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -7
Equity Value 5
Diluted Shares Outstanding, MM 1
Equity Value Per Share 3.96

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financials for Genprex, Inc. (GNPX).
  • Accurate Data: Access to historical data and future projections (highlighted in the yellow cells).
  • Assumption Flexibility: Modify key assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Observe real-time effects of your inputs on Genprex’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.

Key Features

  • Comprehensive GNPX Data: Pre-filled with Genprex’s historical performance metrics and future growth forecasts.
  • Customizable Parameters: Modify key inputs such as revenue projections, profit margins, discount rates, tax implications, and capital investments.
  • Adaptive Valuation Framework: Instantaneous updates to Net Present Value (NPV) and intrinsic value based on user-defined inputs.
  • Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
  • Intuitive Interface: Designed for ease of use, catering to both seasoned professionals and newcomers.

How It Works

  • Download: Obtain the pre-built Excel file featuring Genprex, Inc.'s (GNPX) financial data.
  • Customize: Tailor your forecasts, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategy.

Why Choose Genprex, Inc. (GNPX)?

  • Innovative Solutions: Cutting-edge therapies designed to address unmet medical needs.
  • Strong Scientific Foundation: Backed by robust research and development in gene therapy.
  • Patient-Centric Approach: Focused on improving the quality of life for patients with serious diseases.
  • Experienced Team: Led by industry veterans with a proven track record in biotech.
  • Proven Results: Commitment to delivering effective treatments that show real-world impact.

Who Should Use Genprex, Inc. (GNPX)?

  • Healthcare Students: Understand innovative cancer therapies and their market implications.
  • Researchers: Utilize cutting-edge data for studies on gene therapies and their effectiveness.
  • Investors: Evaluate your investment strategies and analyze the potential of Genprex, Inc. (GNPX) in the biotech sector.
  • Analysts: Enhance your analysis with a comprehensive model tailored for biotech companies.
  • Pharmaceutical Professionals: Discover insights into how emerging biotech firms like Genprex, Inc. (GNPX) are positioned in the market.

What the Template Contains

  • Historical Data: Includes Genprex, Inc.'s (GNPX) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Genprex, Inc.'s (GNPX) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Genprex, Inc. (GNPX).
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions for Genprex, Inc. (GNPX).
  • Quarterly and Annual Statements: A complete breakdown of Genprex, Inc.'s (GNPX) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically for Genprex, Inc. (GNPX).

No products were found matching.